SAN FRANCISCO & SOFIA, Bulgaria–(BUSINESS WIRE)–The EVERY Company (“EVERY”), a leader in highly functional egg proteins produced via precision fermentation, today announced a significant manufacturing expansion with its strategic partner, Huvepharma, a global pharmaceutical company with a focus on developing, manufacturing, and marketing human and animal health products. The agreement quadruples EVERY’s production capacity to meet high demand for its flagship product, OvoPro™, the world’s first commercially available egg protein made via fermentation.

Read more here.